A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

Robert F. Kennedy Jr. said that if he is confirmed he will not collect fees from litigation against the drugmakers of a ...

Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...